TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Vivek MajumderJenna M GregoryMarcelo A BarriaAlison GreenSuvankar PalPublished in: BMC neurology (2018)
These data suggest promise for the use of CSF TDP-43 as a biomarker for ALS.